Septic Shock Non-Survivors have Persistently Elevated Acylcarnitines Following Carnitine Supplementation.

about

Septic Shock Non-Survivors have Persistently Elevated Acylcarnitines Following Carnitine Supplementation.

Item

http://www.wikidata.org/entity/Q49561103

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Septic Shock Non-Survivors hav ...... ing Carnitine Supplementation.

@en

Septic Shock Non-Survivors hav ...... ing Carnitine Supplementation.

@nl

type

Item

label

Septic Shock Non-Survivors hav ...... ing Carnitine Supplementation.

@en

Septic Shock Non-Survivors hav ...... ing Carnitine Supplementation.

@nl

prefLabel

Septic Shock Non-Survivors hav ...... ing Carnitine Supplementation.

@en

Septic Shock Non-Survivors hav ...... ing Carnitine Supplementation.

@nl

P1476

Septic Shock Non-Survivors hav ...... ing Carnitine Supplementation.

@en

P2093

Alan E Jones

http://www.w3.org/2001/XMLSchema#string

Alla Karnovsky

http://www.w3.org/2001/XMLSchema#string

Charles R Evans

http://www.w3.org/2001/XMLSchema#string

Kathleen A Stringer

http://www.w3.org/2001/XMLSchema#string

P2860

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Mortality prediction in patients with severe septic shock: a pilot study using a target metabolomics approach

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine

Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis

Preliminary safety and efficacy of L-carnitine infusion for the treatment of vasopressor-dependent septic shock: a randomized control trial

Comparison of pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after single oral administration of L-carnitine in healthy volunteers.

An adaptive, phase II, dose-finding clinical trial design to evaluate L-carnitine in the treatment of septic shock based on efficacy and predictive probability of subsequent phase III success

Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock.

P304

412-419

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/SHK.0000000000000997

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael A. Puskarich

Arun K Das

P577

2017-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29384504

http://www.w3.org/2001/XMLSchema#string

P932

5847421

http://www.w3.org/2001/XMLSchema#string